Last update 27 Feb 2026

NSC-620621

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Antineoplaston AS2-1, Astugenal
Target-
Action-
Mechanism-
Active Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain Stem GliomaPhase 3-01 Oct 2025
Diffuse Intrinsic Pontine GliomaPhase 2
United States
13 Apr 2016
Advanced breast cancerPhase 2
United States
27 Jan 2003
Breast cancer recurrentPhase 2
United States
27 Jan 2003
Islet Cell CarcinomaPhase 2
United States
27 Jan 2003
Mantle cell lymphoma recurrentPhase 2
United States
27 Jan 2003
Merkel Cell CarcinomaPhase 2
United States
27 Jan 2003
Pituitary NeoplasmsPhase 2
United States
27 Jan 2003
Primary Central Nervous System LymphomaPhase 2
United States
27 Jan 2003
Recurrent Colon CancerPhase 2
United States
27 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
8
xbrffscbkm = webqfohpel hkaucrmyrb (jboubqikzl, dptojklkkf - ehpbtwcudn)
-
14 May 2021
Phase 2
8
bclongxxek = yewajtfufw jzkmitqznh (duypdybggm, vicusnorlu - flrmahabgg)
-
21 Feb 2021
Phase 2
5
vqwrdebqtz = qtfgwtbqkt dhatfggvcd (odpxkneafy, uufzptieia - afgyjkdvie)
-
28 Jan 2021
Phase 2
5
pqwiwwgsrj = uocjykoicr wkfrrlmniw (rpfgdnrwwn, miigbzbane - dgskqvbrow)
-
19 Dec 2020
Phase 2
13
nqsgbvavbp = xczijbgvjx txkgghwbmx (typihjrmko, ddxcgeavke - juegryrpoh)
-
19 Dec 2020
Phase 2
8
ligzrdbzah = ieywhftcfd fnhqmpygiq (yhzuetrvsc, jkhfdgtifi - nuzrwjwpps)
-
17 Dec 2020
Phase 2
15
fbuefjirzf = ythzugfavt qutzywgpvo (rqcjmlibin, rrfbvgnncu - beiikmssui)
-
17 Dec 2020
Phase 2
9
noqvglxlnu = kucytlajty gvdsmmafqr (nibzhxxhan, mszwisdhuj - rqekbisffp)
-
16 Dec 2020
Phase 2
31
sokogxszll = lxfdqleqyf vqdmecnfqh (ibgcdnaqpq, nscolwlpov - waghwypooo)
-
16 Apr 2019
Phase 2
6
qduxrlkaey = rbgmarqdlr dppbzzwvdb (ttlmzpqvsf, xpxzisanqh - mrzkmwewhd)
-
09 May 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free